Nutrition
Volume 26, Issue 6 , Pages 612-616 , June 2010

Lipodystrophy, lipid profile changes, and low serum retinol and carotenoid levels in children and adolescents with acquired immunodeficiency syndrome

  • Tânia Regina Beraldo Battistini, M.Sc.

      Affiliations

    • Department of Pediatrics, ABC School of Medicine, São Paulo, Brazil
    • ,
  • Roseli Oselka Saccardo Sarni, M.D., Ph.D.

      Affiliations

    • Department of Pediatrics, ABC School of Medicine, São Paulo, Brazil
    • Department of Pediatrics, Federal University of São Paulo, São Paulo, Brazil
    • Corresponding Author InformationCorresponding author. Tel./fax: +55-11-5571-9589.
    • ,
  • Fabíola Isabel Suano de Souza, M.D., M.Sc.

      Affiliations

    • Department of Pediatrics, ABC School of Medicine, São Paulo, Brazil
    • Department of Pediatrics, Federal University of São Paulo, São Paulo, Brazil
    • ,
  • Tassiana Sacchi Pitta, M.D.

      Affiliations

    • Department of Pediatrics, ABC School of Medicine, São Paulo, Brazil
    • ,
  • Ana Paula Fernandes, M.D.

      Affiliations

    • Department of Pediatrics, ABC School of Medicine, São Paulo, Brazil
    • ,
  • Sonia Hix, Ph.D.

      Affiliations

    • Department of Pediatrics, ABC School of Medicine, São Paulo, Brazil
    • ,
  • Fernando Luiz Affonso Fonseca, Ph.D.

      Affiliations

    • Department of Pediatrics, ABC School of Medicine, São Paulo, Brazil
    • ,
  • Priscila Chemiotti Tardini, M.D.

      Affiliations

    • Department of Pediatrics, ABC School of Medicine, São Paulo, Brazil
    • ,
  • Valter Pinho dos Santos, M.D., Ph.D.

      Affiliations

    • Department of Pediatrics, ABC School of Medicine, São Paulo, Brazil
    • ,
  • Fábio Ancona Lopez, M.D., Ph.D.

      Affiliations

    • Department of Pediatrics, Federal University of São Paulo, São Paulo, Brazil

Received 20 January 2009 ,Accepted 26 June 2009.

References 

  1. Velasco-Benitez CA. Digestive, hepatic and nutritional manifestations in Latin-American children with HIV/AIDS. J Pediatr Gastroenterol Nutr. 2008;47:S24–S26
  2. Jaquet D, Lèvine M, Ortega-Rodriguez E, Faye A, Polak M, Vilmer E, et al. Clinical and metabolic presentation of the lipodystrophic syndrome in HIV-infected children. AIDS. 2000;14:2123–2128
  3. Noor MA, Seneviratne T, Aweeka FT, Lo JC, Schwarz JM, Mulligan K, et al. Indinavir acutely inhibits insulin-stimulated glucose disposal in humans: a randomized placebo controlled study. AIDS. 2000;16:1–8
  4. Barbaro G, Fisher SD, Lipshultz SE. Pathogenesis of HIV associated cardiovascular complications. J Infect Dis. 2001;1:115–124
  5. Pinti M, Salomoni P, Cossarizza A. Anti-HIV drugs and the mitochondria. Biophys Biochem Acta. 2006;1757:700–707
  6. Tang AM, Lanzilotti J, Hendricks K, Gerrior J, Ghosh M, Woods M, et al. Micronutrient: current issues for HIV care providers. AIDS. 2005;19:847–861
  7. Neves FF, Vanucchi H, Jordão Junior AA, Figueiredo JF. Recommended dose for repair of serum vitamin A levels in patients with infection/AIDS may be insufficient because of high urinary losses. Nutrition. 2006;22:483–489
  8. Temesgen Z, Warnke D, Kasten MJ. Current status of antiretroviral therapy. Expert Opin Pharmacother. 2006;7:1541–1554
  9. Semba RD, Graham NM, Caiaffa WT, Margolick JB, Clement L, Vlahov D. Increased mortality associated with vitamin A deficiency during human immunodeficiency virus type 1 infection. Arch Intern Med. 1993;153:2149–2154
  10. Fawzi WW, Mbise RL, Hertzmark E, Fataki MR, Herrera MG, Ndossi G, et al. A randomized trial of vitamin A supplements in relation to mortality among human immunodeficiency virus-infected and uninfected children in Tanzania. Pediatr Infect Dis J. 1999;18:127–133
  11. Semba R, Ndugwa C, Perry RT, Clark TD, Jackson JB, Melikian G, et al. Effect of periodic vitamin A supplementation on mortality and morbidity of human immunodeficiency virus-infected children in Uganda: a controlled clinical trial. Nutrition. 2005;21:25–31
  12. Fawzi WW, Msamanga GI, Spiegelman D, Wei R, Kapiga S, Villamor E, et al. A randomized trial of multivitamin supplements and HIV disease progression and mortality. N Engl J Med. 2004;351:23–32
  13. Semba R, Lyles C, Margolick J. Vitamin A supplementation and human immunodeficiency virus load in injection drug users. J Infect Dis. 1998;177:611–616
  14. Oh J, Hegele RA. HIV-associated dyslipidemia: pathogenesis and treatment. Lancet Infect Dis. 2007;7:787–796
  15. Currier JS, Lundgren JD, Carr A, Klein D, Sabin CA, Sax PE, et al. Working Group 2. Epidemiological evidence for cardiovascular disease in HIV-infected patients and relationship to highly antiretroviral therapy. Circulation. 2008;118:e29–e35
  16. Grinspoon S. Diabetes mellitus, cardiovascular risk, and HIV disease. Circulation. 2009;119:770–772
  17. Centers for Disease Control and Prevention . Guidelines for the use of antiretroviral agents in pediatric HIV infection. MMWR. 1998;47:1–31
  18. Centers for Disease Control and Prevention . Revised classification system for human immunodeficiency virus infection less than 13 years age. MMWR. 1994;43:1–10
  19. Associação Brasileira de Empresas de Pesquisa–2003. Available at: http://abep.org/codigosguia/ABEP_CCEB.pdf.
  20. Monteiro CA, Nazario CL. Evolução de condicionantes ambientais da saúde na infância na cidade de São Paulo (1984–1996). Rev Saude Publica. 2000;34:13–18
  21. World Health Organization . Physical status. The use and interpretation of anthropometry. WHO technical report series 854. Geneva: World Health Oganization; 1995;p. 452
  22. Kuczmarski RJ, Ogden CL. Grummer-Strawn. CDC growth charts: United States. Advance data from vital and health statistics, no. Hyattsville, MD: National Center for Health Statistics; 2000;314
  23. Marshall EA, Tanner JM. Growth and physiological development during adolescence. Annu Rev Med. 1975;19:283–300
  24. Valente AMM, Reis AF, Machado DM, Succi RCM, Chacra R. Alterações metabólicas da síndrome lipodistrófica do HIV. Arq Bras Endocrinol Metab. 2005;49:871–881
  25. Nierenberg DW, Lester DC. Determination of vitamins A and E in serum using a simplified clarification method and high-performance liquid chromatography. J Chromatogr. 1985;345:275–284
  26. Ford ES, Gillespie C, Ballew C, Sowell A, Mannino DM. Serum carotenoid concentrations in US children and adolescents. Am J Clin Nutr. 2002;76:818–827
  27. National Cholesterol Education Program (NCEP) . Highlights of the report of the expert panel on blood cholesterol levels in children and adolescents. Pediatrics. 1992;89:495–501
  28. Ohkawa H, Oshishi N, Yagi K. Assay for lipid peroxides in animal tissues by thiobarbituric acid reaction. Anal Biochem. 1979;95:351–358
  29. Tresaco B, Bueno G, Pineda I, Moreno LA, Garagorri JM, Bueno M. Homeostatic model assessment (HOMA-IR) index cut-off values to identify the metabolic syndrome in children. J Physiol Biochem. 2005;61:381–388
  30. Dean AG. Epi Info™ and Epi Map: current status and plans for Epi Info™ 2000. J Public Health Manag Pract. 1999;5:54–57
  31. SPSS base 13.0: base users guide. Chicago: SPSS; 2004;
  32. Amaya RA, Kozinetz CA, McMeans A, Schwarzwald H, Kline MW. Lipodystrophy syndrome in human immunodeficiency virus-infected children. Pediatr Infect Dis J. 2002;21:405–410
  33. Santos FS, Rangel LGG, Saucedo GP, Rosales GV, Novales MGM. Hypertriglyceridemia and hypercholesterolemia in human immunodeficiency virus-1 infected children treated with protease inhibitors. Arch Med Res. 2006;37:129–132
  34. Carr A, Samaras K, Thorisdottir A. Diagnosis, prediction, and natural course of HIV-1 protease-inhibitor–associated lipodystrophy, hyperlipidaemia, and diabetes mellitus: a cohort study. Lancet. 1999;353:2093–2099
  35. Verwell G, Saavedra-Lozano J, Van Rossum AMC, Ramilo O, de Groot R. Initiating highly antiretroviral therapy in human immunodeficiency virus type 1 in Europe and the Unites States. Pediatr Infect Dis J. 2006;25:987–994
  36. Shenkin A. Micronutrients in health and disease. Postgrad Med J. 2006;82:559–567
  37. European Pediatric Lipodystrophic Group . Antiretroviral therapy, fat redistribution, and hyperlipidaemia in HIV-infected children in Europe. AIDS. 2004;18:1443–1451
  38. Alves C, Oliveira AC, Brites C. Lypodystrophic syndrome in children and adolescents with the immunodeficiency virus. Braz J Infect Dis. 2008;12:342–348
  39. Friis-Moller N, Reiss P, Sabin CA, Weber R, Monforte A, El-Sadr W, et al. Class of antiretroviral drugs and the risk of myocardial infarction. DAD Study Group. N Engl J Med. 2007;356:1723–1735
  40. Drain PK, Kupka R, Mugusi F, Fawzi WW. Micronutrients in HIV-positive persons receiving highly active antiretroviral therapy. Am J Clin Nutr. 2007;85:333–345
  41. Jared MB, Barbra AR, Daniel DB. Use of serum retinol-binding protein for prediction of vitamin A deficiency. Am J Clin Nutr. 2004;79:218–225
  42. Schindler K, Haider D, Wolzt M, Rieger B, Gmeinhart A, Luger P, et al. Impact of antiretroviral therapy on visfatin and retinol-binding protein 4 in HIV-infected subjects. Eur J Clin Invest. 2006;36:640–646
  43. Srinivas A, Dias BF. Antioxidants in HIV positive children. Indian J Pediatr. 2008;75:347–350
  44. Meagher EA, Fitzgerald GA. Indices of lipid peroxidation in vivo: strengths and limitations. Free Radic Biol Med. 2000;28:1745–1750

 This project was partly supported by Fundação de Amparo à Pesquisa de São Paulo (FAPESP).

PII: S0899-9007(09)00299-8

doi: 10.1016/j.nut.2009.06.024

Nutrition
Volume 26, Issue 6 , Pages 612-616 , June 2010

Article Tools